Observational studyJournal of immunology research2018

Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study.

Bassem I Yamout et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.